Sector: Financials | Industry: Holding Companies |
See Regulatory Filings on SEC |
Company Contact | |
Address: | Kiryat Hamada 5 JERUSALEM 9777605 |
Tel: | N/A |
Website: | https://www.alphatau.com |
IR: | See website |
Key People | ||
Uzi Sofer Chairman of the Board, Chief Executive Officer | Raphi Levy Chief Financial Officer | Amnon Gat Chief Operations Officer |
Ronen Segal Chief Technology Officer | Robert Den Chief Medical Officer | Itzhak Kelson Chief Physics Officer |
Business Overview |
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp. |
Financial Overview |
For the fiscal year ended 31 December 2023, Alpha Tau Medical Ltd revenues was not reported. Net loss decreased 14% to $29.2M. Lower net loss reflects Remeasurement of Warrants decrease from $3.8M (expense) to $0K, Interest from deposits increase from $1.8M to $4.8M (income), Stock-based Compensati decrease of 79% to $474K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.53 to -$0.42. |